Posts by KCAS Bio
March 26
- March 26
KCAS Bio will be attending Innovation for Health in Utrecht, March 26, 2026. This events brings together key players from the Life Sciences & Health ecosystem. Centered on the theme “Bridging the Gap – From Idea to Innovation & from Patent to Patient,” the conference fosters insight sharing, collaboration, and…
April 21
- April 22
KCAS Bio will be attending German Biotech Days in Leipzig, on April 21–22, 2026. German Biotech Days (DBT) bring together entrepreneurs, scientists, and key partners from across the biotech ecosystem, including investors, funding institutions, policymakers, and public administration. Supporting Biologics Drug Development KCAS Bio supports small and large molecule…
March 24
- March 25
KCAS Bio will be attending NextGen Biomed 2026 in London, on March 24–25, 2026. NextGen Biomed is a long-standing, community-driven platform that brings together the biologics and immunotherapy ecosystem to foster interdisciplinary collaboration and knowledge sharing across the R&D lifecycle. Supporting Biologics Drug Development KCAS Bio supports biologics drug…
March 24
- March 25
KCAS Bio will be attending Venture Connect in Durham, North Carolina on March 24-25, 2026. This event Brings together 200+ venture firms and capital sources to hear cutting-edge innovation in multiple verticals, and build strategic relationships that drive fundraising and business development. Venture Connect is the Southeast’s premier capital and…
April 30
- April 30
This new symposium series from PBSS will provide important value to life science industry scientists, since much of the R&D work of our industry nowadays is done at the vendors (CROs, CDMOs, tool makers etc). These scientific symposia will present unique technologies and valuable scientific case studies from vendor labs. …
Blogs
Bioanalysis sits at the intersection of science, regulation, and application. As therapeutic modalities grow more complex and development timelines compress, the role of bioanalysis continues to expand beyond data generation into strategic enablement. To better understand what lies ahead, we asked a diverse group of leaders across KCAS Bio, representing…
News
KCAS Bio is now a Certified Service Provider (CSP) for the ArgoTM HT platform, offering NULISATM services using Alamar Biosciences technology. Our team is fully trained on the Argo™ HT platform to deliver high-quality, reliable, and highly sensitive assay results, whether using custom single-plex assays for low-abundance…
The NULISA™ / Argo™ HT platform is a new, cutting-edge technology with strong potential in ultra-sensitive biomarker detection and targeted proteomics. You can now watch KCAS Bio’s XTalks webinar to learn more about how we leverage this technology for the analysis of low-abundance biomarkers. Abstract In drug…
February 4
- February 4
KCAS Bio is proud to announce our attendance at the Paris Saclay Cancer Cluster (PSCC) Innovation Forum 2026, taking place in Villejuif, France, on February 4, 2026. This event is a one-day oncology-focused meeting centered on innovation, scientific exchange, and ecosystem collaboration. The program includes expert talks on recent breakthroughs…
March 17
- March 21
KCAS Bio is proud to announce our attendance at AD/PD™ 2026 Alzheimer’s & Parkinson’s Diseases Conference – Advances in Science & Therapy – taking place in Copenhagen, Denmark from March 17-21, 2026. This globally recognized conference brings together leading researchers, clinicians, and industry professionals to address the challenges of Alzheimer’s…
March 22
- March 25
KCAS Bio will be exhibiting at the Society of Toxicology (SOT) Annual Meeting and ToxExpo, taking place in San Diego, California on March 22-25, 2026. As one of the largest gatherings of toxicologists and life sciences professionals, this event offers a unique platform to connect with leaders in toxicology and…
March 19
- March 20
KCAS Bio will attending the Boston Society Gene and Cell Therapy Conference, taking place in Cambridge, Massachusetts, on March 19-20, 2026. This event gathers leading experts, innovators, and researchers to explore the latest advancements in gene and cell therapy. Advancing Gene and Cell Therapy with Bioanalytical Expertise Gene and cell…